AlphaMadera's AlphaVal page computes United Parks & Resorts Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag PRKS as undervalued, fairly valued, or overvalued.

What is United Parks & Resorts Inc.'s fair value?

Fair value for PRKS is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value PRKS?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from PRKS's most recent reported fundamentals.

PRKS - United Parks & Resorts Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $48.75 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Mild

Trading 11.2% above fair value

Current Price $36.78

Bear Case $25.56 30.5% downside ($25.56 - $36.78) / $36.78 = -30.5% 3% stage 1 growth, 11% discount

Fair Value $33.08 10.1% downside ($33.08 - $36.78) / $36.78 = -10.1% 4% stage 1 growth, 11% discount

Bull Case $41.74 13.5% upside ($41.74 - $36.78) / $36.78 = 13.5% 5% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

4.2%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (4% base case)

Terminal Value % of EV 34%

Implied Market Multiple 15.7x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $48.75 from 23 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $33.08 per share.

Warnings

ℹ Wall Street's average price target is $48.75 (from 23 analysts). Our estimate is 43% below the consensus -- consider that gap carefully.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions